Status: current, Defined. Date: 31-May 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4567271000168116 | Mvasi (bevacizumab 100 mg / 4 mL) injection, 1 x 4 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4567281000168118 | Mvasi 100 mg/4 mL injection, 4 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mvasi 100 mg/4 mL injection, 4 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Mvasi 100 mg/4 mL injection, 4 mL vial | Is a | bevacizumab 100 mg/4 mL injection, 4 mL vial | true | Inferred relationship | Some | ||
| Mvasi 100 mg/4 mL injection, 4 mL vial | has TP | Mvasi | true | Inferred relationship | Some | ||
| Mvasi 100 mg/4 mL injection, 4 mL vial | has TPUU | Mvasi 100 mg/4 mL injection, 4 mL vial | true | Inferred relationship | Some | 1022269746 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mvasi 100 mg/4 mL injection, 4 mL vial | Is a | True | Mvasi 100 mg/4 mL injection, 4 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR